Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70

United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

Insider

Date

Role

Action

Price

Amount

Alane P Barnes

13 May 2026

Chief Legal Officer

Sold after exercise

62,500

$9.54

$596.25K

Theresa Heggie

20 Mar 2026

Director

Sold after exercise

49,933

$10.11

$504.82K

Alane P Barnes

16 Mar 2026

Chief Legal Officer

Sold after exercise

150,000

$9.15

$1.37M

Alane P Barnes

1 Dec 2025

Chief Legal Officer

Sold after exercise

91,004

$7.10

$646.51K

Show all 14 transactions →

What was left out

Form 4 filings counted 45

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 4

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 2,302,758

History held since 3 Nov 2006